Ficus deltoidea: A Potential Alternative Medicine for Diabetes Mellitus

Table 1

Effect of F. deltoidea extracts and glibenclamide on BRIN BD11 viability.

F. deltoidea extracts	Cell viability (%)
	Control	10 μg/mL	50 μg/mL	100 μg/mL	500 μg/mL	1000 μg/mL
Hot aqueous	100.00±2.62	95.30±4.37	95.54±4.98	95.66±10.19	99.27±6.19	91.29±2.69; (8.71%)*
Ethanolic	100.00±4.84	92.80±1.54 ***; (7.20%)	89.60±3.30 ***; (10.40%)	85.73±1.56 ***; (14.27%)	38.88±0.94 ***; (61.12%)	36.46±1.21 ***; (63.54%)
Methanolic	100.00±6.38	99.32±3.39	97.42±5.62	101.38±2.79	41.80±2.62 ***; (58.20%)	34.42±0.75 ***; (65.58%)
	Control	10 μM	100 μM	200 μM	1000 μM	2000 μM
Glibenclamide	100.00±7.24	95.12±7.33	97.46±7.79	97.96±9.03	59.51±12.76 ***; (40.49%)	32.71±2.79 ***; (67.29%)

Notes: Cells were incubated for 72 hours in the presence of various concentrations of F. deltoidea extracts (10–1000 μg/mL) and glibenclamide (10–2000 μM). Values are expressed as means ± standard deviations (𝑛=8) of percentage of cell viability from three independent assays. *𝑃<0.05; ***𝑃<0.001 compared with control. Values between brackets indicate the percentage of cell viability reduction.